國家衛生研究院 NHRI:Item 3990099045/15433
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 912098      線上人數 : 1114
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15433


    題名: Long dosing intervals of antiosteoporosis medications decrease national fracture risk: A nationwide population-based cohort study
    作者: Fu, SH;Yen, HK;Yang, RS;Lee, CC;Li, CY;Wang, CY
    貢獻者: National Center for Geriatrics and Welfare Research
    摘要: Objective: We hypothesized that long dosing interval antiosteoporosis medications (AOMs), mainly those delivered parenterally, will guarantee higher adherence and persistence, which could help reduce fracture risk. The aim of this research was to evaluate the relationship between different dosing intervals of AOM and the subsequent fracture risk among patients newly initiated AOM therapies. Methods: It is a nationwide population-based cohort study based on Taiwan’s National Health Insurance Research Database. Osteoporosis patients with age C 50 who newly initiated AOM during 2008–2018 (n = 336,229) were included. We categorized AOMs into short dosing intervals (oral AOMs) or long dosing intervals (parenteral AOMs). The adherence and persistence of treatment by medication possession ratio (MPR) and subsequent fracture after treatment for 3 years were measured. Results: Among patients who initiated parenteral AOMs, the percentage of patients with high adherence (MPR C 75%) increased from 33% in 2008 to 69% in 2018. However, among patients who initiated oral AOMs, the percentage of high adherence remained stable (30%) between 2008–2018. The use of parenteral AOMs increased from 1% in 2008 to 62% in 2018. At the same time, the percentage of high adherence of those initiated AOMs significantly increased from 34% in 2008 to 61% in 2018. The risk of subsequent fracture decreased significantly between 2008–2018 after controlling for all potential confounders (hazard ratio = 0.85, 95% CI = 0.81–0.89). Conclusion: AOMs with long dosing intervals not only increased adherence and persistence but also decreased the subsequent fracture risk at a nationwide scale.
    日期: 2023-07-21
    關聯: Aging Clinical and Experimental Research. 2023 Jul 21;35:S143.
    Link to: http://dx.doi.org/10.1007/s40520-023-02442-7
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1594-0667&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001058500201016
    顯示於類別:[王貞予] 會議論文/會議摘要

    文件中的檔案:

    檔案 大小格式瀏覽次數
    ISI001058500201016.pdf70KbAdobe PDF39檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋